Collateral Damage: An Engineering Protocol for Mitigating Chemotherapy Toxicity via Photobiomodulation and Synergistic Therapies
By Dr. Stefano Sinicropi, MD Founder, The HyperCharge Human Engineering Lab EXECUTIVE SUMMARY Modern oncology has achieved remarkable success in targeting malignant cells. However, the management of treatment-related toxicities remains a significant clinical challenge. Chemotherapy-induced adverse events—specifically Oral Mucositis (OM), Chemotherapy-Induced Peripheral Neuropathy (CIPN), and Cancer-Related Cognitive Impairment (CRCI)—significantly degrade patient quality of life and often necessitate dose reductions […]